Skip to main content
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: ACS Chem Neurosci. 2021 Jan 25;12(3):517–530. doi: 10.1021/acschemneuro.0c00737

Figure 7.

Figure 7.

Plasma clearance and metabolism of [18F]PS13 in monkey A. Panel A: reversed phase HPLC analysis of radiometabolites in plasma at 180 min after intravenous radioligand injection at baseline. Panel B: time-course of the percentage of radioactivity in plasma represented by unchanged [18F]PS13 under baseline and preblocked conditions. Panel C: time-course for unchanged [18F]PS13 in plasma under baseline and preblocked conditions.